Farmacy

Jan 7 2018

DSM Pharmaceuticals- Contract manufacturing services #aspen #pharma

#dsm pharma # DSM Pharmaceuticals- Contract manufacturing services DSM Pharmaceuticals, Inc. is one of three business units within the DSM Pharmaceutical Products business group. It is a global provider of finished dosage form manufacturing and related services to the pharmaceutical and biopharmaceutical markets – providing broad capabilities in aseptic filling of liquid and freeze-dried cytotoxic and non-cytotoxic compounds, tablets, capsules, pharmaceutical development services, and clinical trial material manufacturing for solid and injectable forms. These services are centered at a single, technologically-advanced site in Greenville, North Carolina. The facility offers experience going back to the early 1970s, substantially preceding DSM’s nine-year …

Jan 7 2018

DSM says plans to cut 1, 100 jobs prompted by recent pharma moves not shareholder

#dsm pharma # DSM says plans to cut 1,100 jobs prompted by recent pharma moves not shareholder pressure By Gareth MacDonald+ Gareth MACDONALD 25-Aug-2015 2015-08-25T00:00:00Z Last updated on 26-Aug-2015 at 13:46 GMT 2015-08-26T13:46:47Z Royal DSM will make up to 1100 staff redundant by the end of 2017 to cut costs following the formation of its Sinochem JV and pharma products deal with Patheon. The Dutch supplier announced the job cuts today, explaining that the move will save it €125m to €150m ($144m to $173m) over the next two years. DSM said around half of the job cuts will be at …

Jan 7 2018

Shareholder Campaign: Barr Pharmaceuticals #helvoet #pharma

#barr pharma # Shareholder Campaign: Barr Pharmaceuticals Barr Pharmaceuticals, Inc. was a holding company with two main subsidiaries, Barr Laboratories, Inc. and Duramed Pharmaceuticals, that focused on generic and proprietary drugs, respectively. Barr and Duramed developed, manufactured, and marketed more than 100 products. 2005 Resolution: Give the Animals 5 With the help of PETA supporters who held stock in Barr Pharmaceuticals, a resolution was filed in the fall of 2004 calling on the company to Give the Animals 5 replace five crude and cruel animal tests with state-of-the-art and scientifically valid non-animal methods that were already in use in other …

Jan 7 2018

How Big Pharma got the better of Ottawa – The Globe and Mail #outsourcing #pharma

#big pharma jobs # How Big Pharma got the better of Ottawa Add to. Dr. John Bergeron pulls his car off Highway 40 in west Montreal and turns into a desolate parking lot beside a sprawling complex of buildings. Walking across the parking lot, he greets two men. One of them is Dr. Ronald Guttmann, who, like Bergeron, is a retired McGill professor who has spent many years working on the discovery, development and commercialization of new drugs. The third man is Dr. Samir Mounir, a scientific entrepreneur and former team leader at BioChem Pharma, which at one time was …

Jan 7 2018

Forest pharma #fdc #pharma

#forest pharma # Actavis/Forest Laboratories Before outdoing itself with its $66 billion Allergan ($AGN) buyout, Actavis ($ACT) had the biggest buy of 2014’s first half with its acquisition of Forest Labs. And with two deal-minded CEOs at the helm, this one happened quickly. When the pair first met at 2014’s J.P. Morgan Healthcare Conference, then-Actavis CEO Paul Bisaro had already merged Watson Pharmaceuticals with generics maker Actavis and then nabbed Ireland’s Warner Chilcott to build up on the branded side. Brand-new Forest CEO Brent Saunders had just stepped into the skipper’s chair after Valeant ($VRX) bought up Bausch + Lomb, …

Jan 7 2018

Latest Pharma jobs in Prague and Brno #life #cycle #pharma

#pharmajobs # Pharma jobs Dealing exclusively in pharmaceutical, biotechnology, generics, CRO and medical device jobs across in the Czech Republic and Slovakia, our Life Sciences consultants have an in-depth understanding of their specialism and all the latest industry trends and developments. They possess a wealth of industry experience, recruiting for a range of life sciences jobs for the world’s leading companies in the pharmaceutical, biotechnology, generics, CRO and medical device industries. We use this detailed insight to help our candidates find the right Pharma job so that they can transform their careers and make a real impact on the organisations …

Jan 7 2018

UCB to buy Schwarz Pharma for $5 #biotech #company

#schwarz pharma # UCB to buy Schwarz Pharma for $5.6 billion LONDON (MarketWatch) — Belgium’s UCB on Monday said it agreed to pay $5.6 billion for Germany’s Schwarz Pharma, the third multibillion-dollar takeover in the European pharmaceutical industry in the past five days. UCB (000373953) said it’s paying 4.4 billion euros in cash and shares, representing a 20% premium to Friday’s close, for Schwarz Pharma (722190). The deal follows proposals by Germany’s Merck KGaA (659990) to buy Switzerland’s Serono SRA, +0.00% for $13.3 billion, and Denmark’s Nycomed to buy the pharmaceutical operations of Germany’s Altana AAA, +8.70% for $5.8 billion. …

Jan 7 2018

Pharma india #china #pharmaceutical #industry

#pharma india # AstraZeneca Pharma India Limited (AZPIL) has interests in seven crucial areas of healthcare: • Brilinta® (Ticagrelor Tablets 90mg) • Betaloc® (Metoprolol Tartrate Tablets IP 25mg, 50mg 100mg) • Seloken XL® (Metoprolol Succinate Extended Release Tablets USP 25mg, 50mg 100mg) • Imdur® (Prolonged Release Isosorbide-5-Mononitrate Tablets BP 30mg 60mg) • Crestor® (Rosuvastatin Tablets IP 5mg, 10mg, 20mg 40mg) • Seloram™ (Metoprolol Succinate Extended Release Ramipril Tablets 25/2.5mg, 25/5mg 50/5mg) • Vigocil® (Voglibose Orally Disintegrating Tablets 0.2mg 0.3mg) • Vigocil M® (Voglibose and Metformin Hydrochloride Tablets 0.2/500mg 0.3/500mg) • Nitract SR™ (Nitroglycerin Sustained Release Capsules 2.5mg 6.5mg) • Valfect™ …

Jan 7 2018

Actavis to Buy Forest Laboratories for $25 Billion #penn #pharma

#forest pharma # Actavis to Buy Forest Laboratories for $25 Billion Actavis Plc, the world’s second-largest generic-drug maker by market value, agreed to buy Forest Laboratories Inc. for about $25 billion in a deal that will transform it into a developer of brand-name drugs. The deal is a win for billionaire investor Carl Icahn, Forest’s second-largest holder who gained seats on the company’s board in 2012 and 2013, and pushed for a sale. Forest investors will get cash and stock valued at $89.48 a share, based on the Feb. 14 closing price, the companies said today in a statement. The …

Jan 7 2018

Something I Have Noticed About Kava #the #drug #company

#pharma kava # One thing I’ve definitely noticed about kava is that, like weed, it can have pretty drastically different effects depending on where it is sourced from and how it is grown. The variations can be quite huge like that between different strains of marijuana. I’ve tried a lot and I’ve noticed that in general, kava from Hawaii is a very mellow, mood elevating and socially enhancing buzz. whereas some kava I’ve had from Vanuatu has been WAY stronger with more of a body numbing, completely inebriating fucks you up kind of buzz. Some kava I enjoy, and some …